Ryan Lee Basden, Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 347 S Gladstone Ave, Aurora, IL 60506 Phone: 618-973-0615 |
Ronald C Gregus, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Accepting Medicare Assignments Practice Location: 4000 Ogden Ave, Aurora, IL 60504 Phone: 615-778-4066 |
Dr. Charles Graham Woodward, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1320 N. Highland Ave., Aurora, IL 60506 Phone: 630-859-8159 Fax: 630-859-8474 |
Eric Raul Simental, Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1014 Claim St, Aurora, IL 60505 Phone: 630-674-0898 |
News Archive
Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
Disease interventions, such as the use of insecticide-treated nets to prevent malaria and increased access to HIV treatment and prevention, have helped reduce the number of deaths among children younger than age five worldwide to 9.2 million in 2007, down from 9.7 million in 2006 and 12.7 million in 1990, according to a UNICEF report published Friday in the journal Lancet, Reuters reports (Kahn, Reuters, 9/12).
Health Diagnostic Laboratory, Inc., a leader in disease state management, today announced its new capability to run the CYP2C19 genetic test. HDL, Inc., headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile.
› Verified 2 days ago